Related Experiment Video
Updated: Jul 12, 2025

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
41.2K
Metastatic Neoplasms to the Breast
Mine Özşen1, Sahsine Tolunay1, Seyit Ali Volkan Polatkan2
1Department of Pathology, Faculty of Medicine, Uludag University, Bursa, Turkey.
International Journal of Surgical Pathology
|October 30, 2023
Summary
Distinguishing metastatic breast tumors from primary ones requires careful clinicopathological analysis. This study highlights key features of non-hematopoietic metastatic neoplasms to aid accurate diagnosis and patient management.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Metastatic breast lesions can be misdiagnosed as primary breast neoplasms, especially when clinical information is limited.
- Non-hematopoietic metastatic neoplasms to the breast present diagnostic challenges.
Purpose of the Study:
- To present cases of non-hematopoietic metastatic breast neoplasms.
- To evaluate clinicopathological features that differentiate metastatic from primary breast neoplasms.
Main Methods:
- Retrospective analysis of breast resection materials diagnosed with metastatic non-hematopoietic neoplasms between 2010-2023.
- Evaluation of clinicopathological features of included cases.
Main Results:
- 15 cases of metastatic non-hematopoietic breast neoplasms were analyzed.
- Carcinoma (60%), melanoma (33%), and sarcoma (7%) were the most frequent metastatic malignancies.
- Primary sites for metastatic carcinoma included lung, gastrointestinal tract, female genital tract, and kidney.
Conclusions:
- Accurate diagnosis of metastatic breast neoplasms is crucial for patient management and prognosis.
- Histomorphological and immunohistochemical evaluation, combined with clinicoradiological data, are essential.
- Differentiating metastatic from primary breast tumors requires a comprehensive approach.
Related Concept Videos
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

